Taiwan
· Delayed Price · Currency is TWD Oneness Biotech Statistics
Total Valuation
Oneness Biotech has a market cap or net worth of TWD 71.81 billion. The enterprise value is 65.15 billion.
| Market Cap | 71.81B |
| Enterprise Value | 65.15B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Oneness Biotech has 477.12 million shares outstanding. The number of shares has increased by 1.75% in one year.
| Shares Outstanding | 477.12M |
| Shares Change (YoY) | +1.75% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 7.82% |
| Owned by Institutions (%) | 4.71% |
| Float | 314.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.32 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -66.56 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -155.43 |
Financial Position
The company has a current ratio of 45.27, with a Debt / Equity ratio of 3.05.
| Current Ratio | 45.27 |
| Quick Ratio | 44.25 |
| Debt / Equity | 3.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.02 |
| Interest Coverage | -134.24 |
Financial Efficiency
Return on equity (ROE) is -6.83% and return on invested capital (ROIC) is -4.71%.
| Return on Equity (ROE) | -6.83% |
| Return on Assets (ROA) | -4.59% |
| Return on Capital (ROIC) | -4.71% |
| Revenue Per Employee | 2.37M |
| Profits Per Employee | -22.76M |
| Employee Count | 43 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.45 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.72% in the last 52 weeks. The beta is 1.59, so Oneness Biotech's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | -11.72% |
| 50-Day Moving Average | 154.71 |
| 200-Day Moving Average | 160.72 |
| Relative Strength Index (RSI) | 45.86 |
| Average Volume (20 Days) | 2,172,178 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oneness Biotech had revenue of TWD 101.93 million and -978.89 million in losses. Loss per share was -2.06.
| Revenue | 101.93M |
| Gross Profit | 49.15M |
| Operating Income | -1.11B |
| Pretax Income | -976.51M |
| Net Income | -978.89M |
| EBITDA | -684.27M |
| EBIT | -1.11B |
| Loss Per Share | -2.06 |
Balance Sheet
The company has 7.54 billion in cash and 425.90 million in debt, giving a net cash position of 7.12 billion or 14.92 per share.
| Cash & Cash Equivalents | 7.54B |
| Total Debt | 425.90M |
| Net Cash | 7.12B |
| Net Cash Per Share | 14.92 |
| Equity (Book Value) | 13.95B |
| Book Value Per Share | 28.27 |
| Working Capital | 7.64B |
Cash Flow
In the last 12 months, operating cash flow was -342.85 million and capital expenditures -76.32 million, giving a free cash flow of -419.18 million.
| Operating Cash Flow | -342.85M |
| Capital Expenditures | -76.32M |
| Free Cash Flow | -419.18M |
| FCF Per Share | -0.88 |
Margins
| Gross Margin | 48.22% |
| Operating Margin | -1,087.36% |
| Pretax Margin | -958.06% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -411.25% |
Dividends & Yields
Oneness Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -1.75% |
| Shareholder Yield | -1.75% |
| Earnings Yield | -1.37% |
| FCF Yield | -0.58% |
Stock Splits
The last stock split was on July 26, 2024. It was a forward split with a ratio of 1.049967976.
| Last Split Date | Jul 26, 2024 |
| Split Type | Forward |
| Split Ratio | 1.049967976 |